Intelligent Bio Solutions Updates Shares Outstanding to 3,018,188

What Happened

• Intelligent Bio Solutions Inc. filed an 8-K (Item 8.01) reporting that the company had 3,018,188 shares of common stock outstanding as of the close of business on July 31, 2026.
• The change in shares resulted from (a) sales under the company’s At-The-Market Offering Agreement with Ladenburg Thalmann & Co. Inc. (dated September 18, 2024), (b) exercises of previously disclosed outstanding warrants, and (c) issuance of restricted common stock under an Investor Relations and Corporate Development Advisory Agreement with ClearThink Capital Partners LLC (dated February 29, 2024).

Key Details

• Total outstanding common shares: 3,018,188 (as of July 31, 2026).
• At-The-Market (ATM) sales executed under agreement with Ladenburg Thalmann & Co. Inc.; ATM agreement dated September 18, 2024.
• Additional shares issued via warrant exercises (previously disclosed).
• Restricted shares issued under advisory agreement with ClearThink Capital Partners LLC dated February 29, 2024.

Why It Matters

• The updated share count is a basic but important metric for investors: it affects per-share measures such as earnings per share (EPS), ownership percentages, and voting power.
• Increases in outstanding shares can dilute existing shareholders’ percentages of ownership and influence market capitalization and per-share valuations even if company value hasn’t changed.
• Investors should factor the new share total into any per‑share calculations and monitor future filings for further issuances, warrant exercises, or ATM activity.